Pancreatic Cancer Action Network Calls for Immediate, Sustained Investment in Research Toward Early Detection and Treatment ...

Because 13% survival is not enough, PanCAN has set a bold goal: Drive the five-year survival rate to 20% by 2030. We will do ...

To kick off 2026, PanCAN’s Volunteer Advisory Council shares a warm message of advice and encouragement with PanCAN ...

PanCAN board member Sharon Petry Bittman lost her husband to pancreatic cancer in 2018 and has been committed to raising ...

If there’s a way to shine a light on PanCAN, Marco Argenti has done it. This year, Marco added Team PanCAN to the list, running the New York City Half Marathon in March and, during Pancreatic Cancer ...

This Pancreatic Cancer Awareness Month, PanCAN is inviting you to shine a light on pancreatic cancer. Let’s uplift survivors and those living with the disease, honor the lives we’ve lost and help ...

With No Standard Early Detection Test for the General Public, Leading Nonprofit Dedicated to Advancing Progress Encourages Knowing Risks, Symptoms and Advocates for More Funding LOS ANGELES, Calif.

Editor’s note: In this heartfelt interview, Jaylen Baron shares the story of her mother, Jane – an inspiring dance teacher, mentor and fighter – whose legacy is honored every year at PanCAN ...

The U.S. Food & Drug Administration has granted approval for a new drug to treat pancreatic neuroendocrine tumors, also called PNET or PanNET. “I am delighted that patients with pancreatic ...

PanCAN’s Early Detection Initiative (EDI) has reached an important milestone: The study has enrolled all the patients necessary to move on to the next stage of this groundbreaking work that explores ...

Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and New Treatments for Patients LOS ANGELES, Calif. – (January 16, 2025) – After ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...